Case Study: Glaucoma Treatment with coMra Therapy
Introduction to Glaucoma
- Complex eye disease related to the health and resiliency of the optic nerve
- Raised intraocular pressure is a risk factor, not diagnostic criteria
- Possible to have glaucoma with low or high intraocular pressure
Patient Profile
- Gender: Female
- Age: In her 50s
- Diagnosed with glaucoma in 2011
Initial Symptoms and Diagnosis
- High intraocular pressure
- Optic nerve inferior rim thinning in both eyes
- Nearsighted (corrected with lenses)
- Allergic skin reactions on face and neck to glaucoma medications
coMra Treatment Protocol
- 48 treatments over 28 days (Autumn 2016)
- Each treatment approximately 20 minutes
- Used Neurology 14 treatment protocol
Treatment Outcomes
October 2016 Checkup
- Intraocular pressure improvements:
- Both eyes: 14 mm Hg (lowest ever recorded)
- Increased field of vision (noticed after first week)
- Resolution of skin rash
Additional Treatments
- Herbal supplements for detoxification (skin, kidney, lymph, liver, bowel)
- Eye-specific supplements
- General vitamin and mineral supplements
Medication
- Patient still using one type of eye drops under medical supervision
- List of previously used medications provided (not detailed in summary)
Notes on Optic Nerve Inferior Rim Thinning
- Refers to thinning at the bottom of the optic disc (optic nerve)
Conclusion
Quote from Théun Mares, founder of Radiant Life Technologies:
“The state of well-being is something that has to be experienced before one even knows that it exists. Once it has been discovered, it needs to be nurtured and tended with care.”
Note: coMra therapy is reported to work synergistically with other therapies, both invasive and non-invasive, potentially improving overall outcomes.